Olenka Caffo1, Penny A Ralston2, Jennifer L Lemacks3, Iris Young-Clark2, Kandauda K A S Wickrama4, Jasminka Z Ilich5. 1. College of Medicine, Florida State University, Tallahassee, Florida, USA. 2. Center on Better Health and Life for Underserved Populations, Florida State University, Tallahassee, Florida, USA. 3. School of Kinesiology and Nutrition, University of Southern Mississippi, Hattiesburg, Mississippi, USA. 4. Human Development and Family Science Research, University of Georgia, Athens, Georgia, USA. 5. Institute for Successful Longevity, Consulting Faculty, Center on Better Health and Life for Underserved Populations, Florida State University, Tallahassee, Florida, USA.
Abstract
Objective: Cardiovascular disease (CVD) continues to be a leading cause of death for U.S. adults, especially African Americans (AA). Yet, few studies have examined a comprehensive set of metabolic health and health behavior factors related to CVD risk in this population. This study investigated the relationship between serum leptin and anthropometries (body mass index [BMI], circumferences [waist-WC, hip-HC, and waist/hip ratio W/H]), metabolic health (systolic and diastolic blood pressure [BP], serum lipids, glucose, and C-reactive protein [CRP]), and health behaviors (hours of sleep, physical activity) in midlife and older AAs. Materials and Methods: Participants (n = 89, ≥45 years of age) were AAs in six churches in North Florida enrolled in a broader church-based longitudinal study. Anthropometric measurements, serum analyses, and self-reported items. Results: Serum leptin was positively correlated with gender (being female) (r = 0.623, p < 0.001), BMI log transformed (r = 0.469, p < 0.001), WC (r = 0.440, p < 0.001), HC (r = 0.658, p < 0.001), use of BP medication (r = 0.216, p < 0.05), and serum CRP (r = 0.277, p < 0.01). Correlations by sex showed significant relationships for both men and women between leptin and BMI log transformed, WC, and HC. The final multiple regression model [R2 = 0.758, F(4, 66) = 55.871, p < 0.001] showed that 75.8% of the variance in leptin was explained by being female (β = 0.65, p < 0.001), WC (β = 0.26, p < 0.02), and HC (β = 0.28, p < 0.01). Conclusions: Findings more specifically delineate the variables associated with serum leptin in AAs, particularly WC and HC, and suggest greater attention to possible risk for leptin resistance in AA females. Clinical Trial Registration: This study is registered at www.clinicaltrials.gov NCT03339050.
Objective: Cardiovascular disease (CVD) continues to be a leading cause of death for U.S. adults, especially African Americans (AA). Yet, few studies have examined a comprehensive set of metabolic health and health behavior factors related to CVD risk in this population. This study investigated the relationship between serum leptin and anthropometries (body mass index [BMI], circumferences [waist-WC, hip-HC, and waist/hip ratio W/H]), metabolic health (systolic and diastolic blood pressure [BP], serum lipids, glucose, and C-reactive protein [CRP]), and health behaviors (hours of sleep, physical activity) in midlife and older AAs. Materials and Methods: Participants (n = 89, ≥45 years of age) were AAs in six churches in North Florida enrolled in a broader church-based longitudinal study. Anthropometric measurements, serum analyses, and self-reported items. Results: Serum leptin was positively correlated with gender (being female) (r = 0.623, p < 0.001), BMI log transformed (r = 0.469, p < 0.001), WC (r = 0.440, p < 0.001), HC (r = 0.658, p < 0.001), use of BP medication (r = 0.216, p < 0.05), and serum CRP (r = 0.277, p < 0.01). Correlations by sex showed significant relationships for both men and women between leptin and BMI log transformed, WC, and HC. The final multiple regression model [R2 = 0.758, F(4, 66) = 55.871, p < 0.001] showed that 75.8% of the variance in leptin was explained by being female (β = 0.65, p < 0.001), WC (β = 0.26, p < 0.02), and HC (β = 0.28, p < 0.01). Conclusions: Findings more specifically delineate the variables associated with serum leptin in AAs, particularly WC and HC, and suggest greater attention to possible risk for leptin resistance in AA females. Clinical Trial Registration: This study is registered at www.clinicaltrials.gov NCT03339050.
Entities:
Keywords:
African American women; African Americans; body circumferences; cardiovascular risk factors; leptin
Authors: Jane F Owens; Daniel J Buysse; Martica Hall; Thomas W Kamarck; Laisze Lee; Patrick J Strollo; Steven E Reis; Karen A Matthews Journal: J Clin Sleep Med Date: 2010-08-15 Impact factor: 4.062
Authors: Penny A Ralston; Jennifer L Lemacks; Kandauda K A S Wickrama; Iris Young-Clark; Catherine Coccia; Jasminka Z Ilich; Cynthia M Harris; Celeste B Hart; Arrie M Battle; Catherine Walker O'Neal Journal: Contemp Clin Trials Date: 2014-03-28 Impact factor: 2.226
Authors: Sara García-Jiménez; German Bernal Fernández; Maria Fernanda Martínez Salazar; Antonio Monroy Noyola; Cairo Toledano Jaimes; Angelica Meneses Acosta; Leticia Gonzalez Maya; Elizabeth Aveleyra Ojeda; Maria A Terrazas Meraz; Marie-Catherine Boll; Miguel A Sánchez-Alemán Journal: J Clin Lab Anal Date: 2014-03-22 Impact factor: 2.352
Authors: Sarah S Cohen; Jay H Fowke; Qiuyin Cai; Maciej S Buchowski; Lisa B Signorello; Margaret K Hargreaves; Wei Zheng; William J Blot; Charles E Matthews Journal: Ann Nutr Metab Date: 2012-02-18 Impact factor: 3.374
Authors: Charles X Kim; Kent R Bailey; George G Klee; Allison A Ellington; Guanghui Liu; Thomas H Mosley; Hamid Rehman; Iftikhar J Kullo Journal: PLoS One Date: 2010-02-05 Impact factor: 3.240